Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe

Two classes of antiviral drugs are licensed in Europe for treatment and prophylaxis of influenza; the M2 ion-channel blockers amantadine and rimantadine acting against type A influenza viruses only and the neuraminidase enzyme inhibitors zanamivir and oseltamivir acting against type A and type B inf...

Full description

Bibliographic Details
Main Author: Pozo, F. (author)
Other Authors: Bruno, L. (author), Rebelo-de-Andrade, H. (author), Vicent, E. (author), Rossyvaikis, A. (author), Broger, E. (author), Daniel, R. (author), Lankenby, A. (author), Meijer, A. (author)
Format: article
Language:eng
Published: 2015
Subjects:
Influenza
Antiviral Drugs
Susceptibility Testing
Guidance
Resistência aos Antimicrobianos
Online Access:http://hdl.handle.net/10400.18/2935
Country:Portugal
Oai:oai:repositorio.insa.pt:10400.18/2935

Internet

http://hdl.handle.net/10400.18/2935

Similar Items